As shown in Table 2, tumours in DRPI-PG2 were associated with adverse clinicopathological features including higher histologic grade (p = 0.045), lympho-vascular invasion (p = 0.001), and Her-2 overexpression (p = 0.046). The gene discussed is ERBB2; the disease is neoplasm.